Nano-Resveratrol: A Promising Candidate for the Treatment of Renal Toxicity Induced by Doxorubicin in Rats Through Modulation of Beclin-1 and mTOR

Background: Although doxorubicin (DXR) is one of the most used anticancer drugs, it can cause life-threatening renal damage. There has been no effective treatment for DXR-induced renal damage until now. Aim: This work aims at examining the potential impact of nano-resveratrol (N-Resv), native resver...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhusaini, Ahlam M., Fadda, Laila M., Alanazi, Abeer M., Sarawi, Wedad S., Alomar, Hatun A., Ali, Hanaa M., Hasan, Iman H., Ali, Rehab Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913579/
https://www.ncbi.nlm.nih.gov/pubmed/35281939
http://dx.doi.org/10.3389/fphar.2022.826908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913579/
https://www.ncbi.nlm.nih.gov/pubmed/35281939
http://dx.doi.org/10.3389/fphar.2022.826908

Ejemplares similares